135 related articles for article (PubMed ID: 38006459)
21. Synthesis,
Lin P; Zeng JC; Chen JG; Nie XL; Yuan E; Wang XQ; Peng DY; Yin ZP
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1879-1890. PubMed ID: 33003963
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory kinetics and mechanism of rifampicin on α-glucosidase: Insights from spectroscopic and molecular docking analyses.
Lin MZ; Chai WM; Zheng YL; Huang Q; Ou-Yang C
Int J Biol Macromol; 2019 Feb; 122():1244-1252. PubMed ID: 30227201
[TBL] [Abstract][Full Text] [Related]
23. A New Series of Salicylic Acid Derivatives as Non-saccharide α-Glucosidase Inhibitors and Antioxidants.
Chen J; Lu W; Chen H; Bian X; Yang G
Biol Pharm Bull; 2019 Feb; 42(2):231-246. PubMed ID: 30504654
[TBL] [Abstract][Full Text] [Related]
24. Novel Insights into the Inhibitory Effect and Mechanism of Proanthocyanidins from Pyracantha fortuneana Fruit on α-Glucosidase.
Wei M; Chai WM; Yang Q; Wang R; Peng Y
J Food Sci; 2017 Oct; 82(10):2260-2268. PubMed ID: 28906013
[TBL] [Abstract][Full Text] [Related]
25. Phenolics from Eugenia jambolana seeds with advanced glycation endproduct formation and alpha-glucosidase inhibitory activities.
Liu F; Ma H; Wang G; Liu W; Seeram NP; Mu Y; Xu Y; Huang X; Li L
Food Funct; 2018 Aug; 9(8):4246-4254. PubMed ID: 30009284
[TBL] [Abstract][Full Text] [Related]
26. Molecular docking of polyoxometalates as potential α-glucosidase inhibitors.
Hu J; Wang L; Wang F; Chi G; Liu G; Sun L
J Inorg Biochem; 2020 Feb; 203():110914. PubMed ID: 31751818
[TBL] [Abstract][Full Text] [Related]
27. Investigation on the Enzymatic Profile of Mulberry Alkaloids by Enzymatic Study and Molecular Docking.
Liu Z; Yang Y; Dong W; Liu Q; Wang R; Pang J; Xia X; Zhu X; Liu S; Shen Z; Xiao Z; Liu Y
Molecules; 2019 May; 24(9):. PubMed ID: 31071910
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
29. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
[TBL] [Abstract][Full Text] [Related]
31. Discovery of potent α-glucosidase inhibitor flavonols: Insights into mechanism of action through inhibition kinetics and docking simulations.
Şöhretoğlu D; Sari S; Barut B; Özel A
Bioorg Chem; 2018 Sep; 79():257-264. PubMed ID: 29778797
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
35. α-Glucosidase inhibitory effect of an anthraquinonoid produced by Fusarium incarnatum GDZZ-G2.
Fan J; Lv C; Li Z; Guo M; Yin Y; Wang H; Wang W; Sun S
J Basic Microbiol; 2022 Nov; 62(11):1360-1370. PubMed ID: 35736630
[TBL] [Abstract][Full Text] [Related]
36. Identification of 1,3,4-oxadiazolyl-containing β-carboline derivatives as novel α-glucosidase inhibitors with antidiabetic activity.
Xiao D; Lu L; Liang B; Xiong Z; Xu X; Chen WH
Eur J Med Chem; 2023 Dec; 261():115795. PubMed ID: 37688939
[TBL] [Abstract][Full Text] [Related]
37. Triterpenic Acids as Non-Competitive α-Glucosidase Inhibitors from
Ur Rehman N; Halim SA; Al-Azri M; Khan M; Khan A; Rafiq K; Al-Rawahi A; Csuk R; Al-Harrasi A
Biomolecules; 2020 May; 10(5):. PubMed ID: 32408614
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as α-glucosidase inhibitors with antidiabetic activity.
Hu C; Liang B; Sun J; Li J; Xiong Z; Wang SH; Xuetao X
Eur J Med Chem; 2024 Jan; 264():115957. PubMed ID: 38029465
[TBL] [Abstract][Full Text] [Related]
39. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
